生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1161 生物科技

收市竞价 07-29 16:00:00

6,554.552

+216.020

+3.41%

最高6,581.361	最低6,297.580	成交量5.34亿
今开6,339.352	昨收6,338.532	日振幅4.48%
总市值0.00	流通市值0.00	总股本0.00
成交额145.32亿	换手率--	流通股本0.00
市净率8.681431	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1161","market":"HK","secType":"PLATE","nameCN":"生物科技","latestPrice":6554.552,"timestamp":1753776244570,"preClose":6338.5317,"halted":0,"volume":534314932,"delay":0,"changeRate":0.03408,"floatShares":0,"shares":0,"eps":0,"marketStatus":"收市竞价","change":216.02002,"latestTime":"07-29 16:00:00","open":6339.352,"high":6581.3613,"low":6297.5796,"amount":14531847810,"amplitude":0.044771,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753776600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753752600000,1753761600000],[1753765200000,1753776000000]],"pbRate":8.681431,"peRate":-61.316982,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1161","defaultTab":"news","newsList":[{"id":"2555080182","title":"ETF收评 | 创新药板块爆发，港股通创新药ETF涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555080182","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555080182?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:12","pubTimestamp":1753773163,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["000001.SH","159561","BK1161","HSTECH","515120","150227","159992","399001","BK4614","HSCEI","FDN","515980","513030","399006","BK4550","399300","07226","BK1574","513080","BK4585","06978","BK4588","515290","159583","161121","YANG","159915","159982","510010"],"gpt_icon":0},{"id":"2555877890","title":"大行评级｜招银国际：上调三生制药目标价至37.67港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555877890","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555877890?lang=zh_cn&edition=full","pubTime":"2025-07-29 14:42","pubTimestamp":1753771353,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","LU0321505439.SGD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","III","LU1883839398.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0321505868.SGD","LU0868494617.USD","BK4585","BK4534","BK4568","BK1593","BK4588","LU0225284248.USD","SG9999002232.USD","IE0002270589.USD","LU0234572021.USD","LU0985481810.HKD","SG9999013999.USD","BK4134","BK1161","BK4599","IE00BLSP4452.SGD","LU0289739699.SGD","LU1169589451.USD","LU1023059063.AUD","IE00BLSP4239.USD","PD","LU0058720904.USD","LU1894683348.USD","BK4023","LU1066051498.USD","PFE","IE00B19Z3581.USD","BK4592","LU0225771236.USD","SG9999002224.SGD","IE000M9KFDE8.USD","SG9999003800.SGD","BK4007","01530","BK4550","IE00BBT3K403.USD","BK1583","LU0306807586.USD","SG9999001176.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2555708769","title":"利好突袭！刚刚，全线爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2555708769","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555708769?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:43","pubTimestamp":1753767780,"startTime":"0","endTime":"0","summary":"　　7月29日，A股、港股市场创新药板块再度全线爆发，多只个股大涨超10%。消息面上，创新药赛道大涨主要受业绩超预期、海外大订单与政策三大利好驱动。　　港股创新药板块亦全线爆发，药明康德大涨超10%，先声药业、绿叶制药涨超8%，泰格医药涨超7%，石药集团、微创医疗涨超6%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-07-29/doc-inficncz1052688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399300","BK1574","GSK","159982","BK1515","GSK.UK","HSTECH","BK4585","BK1161","06978","09939","HSCEI","BK4588","BK4614","LU1829250122.USD","YANG","BK4532","BK4007"],"gpt_icon":1},{"id":"2555308240","title":"瑞银：升三生制药(01530.HK)目标价至41港元 看好SSGJ-707销售表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555308240?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:39","pubTimestamp":1753767544,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1593","BK1583","01530"],"gpt_icon":0},{"id":"2555716084","title":"君实生物盘中异动 下午盘股价大涨5.13%报28.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555716084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555716084?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:32","pubTimestamp":1753767147,"startTime":"0","endTime":"0","summary":"2025年07月29日下午盘13时32分，君实生物股票出现波动，股价大幅拉升5.13%。截至发稿，该股报28.700港元/股，成交量1156.32万股，换手率4.44%，振幅7.69%。资金方面，该股资金流入1.54939亿港元，流出1.11814亿港元。君实生物股票所在的生物技术行业中，整体涨幅为3.19%。其相关个股中，药明巨诺-B、创胜集团-B、东曜药业-B涨幅较大，振幅较大的相关个股有药明巨诺-B、创胜集团-B、北海康成-B，振幅分别为30.52%、27.09%、18.68%。药品批发,药品委托生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729133227a6c72a98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729133227a6c72a98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1583","01877","688180"],"gpt_icon":0},{"id":"2555308411","title":"研报掘金丨中邮证券：贵州百灵盈利能力及控费能力显著提升，首予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308411","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555308411?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:27","pubTimestamp":1753766873,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1141","BK1576","BK1583","002424","BK0077","03347","BK1161","BK0239","BK1574","BK0183","BK0146","399441","161726","159992","BK0188","BK0028","161027","06978"],"gpt_icon":0},{"id":"2555084925","title":"圣诺医药-B盘中异动 下午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555084925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555084925?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:08","pubTimestamp":1753765717,"startTime":"0","endTime":"0","summary":"2025年07月29日下午盘13时08分，圣诺医药-B股票出现异动，股价急速上涨5.19%。截至发稿，该股报8.310港元/股，成交量57.105万股，换手率0.54%，振幅6.71%。圣诺医药-B股票所在的生物技术行业中，整体涨幅为4.07%。其相关个股中，药明巨诺-B、创胜集团-B、东曜药业-B涨幅较大，振幅较大的相关个股有药明巨诺-B、创胜集团-B、北海康成-B，振幅分别为30.52%、27.09%、18.68%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130837a6c723b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130837a6c723b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2555081071","title":"政策与业绩双重利好，创新药板块迎来火爆行情丨一大板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2555081071","media":"第一财经","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555081071?lang=zh_cn&edition=full","pubTime":"2025-07-29 12:51","pubTimestamp":1753764660,"startTime":"0","endTime":"0","summary":"7月29日，CRO、创新药等医药板块强势，九州药业涨停，药石科技，泰格科技涨超10%。消息面上，国家医保局日前表示，第十一批集采将优化具体规则，不再简单以最低报价作为参考，而是坚持“稳临床、保质量、防围标、反内卷”的原则；泰格医药宣布完成对日本CRO公司Micron的收购；药明康德公告2025年半年报预增，预计归母净利润同比增长约101.9%。Wind创新药指数近一个月上涨27%。机构认为，集采反内卷优化行业生态，创新药行业成长动能强劲。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912543897249aba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912543897249aba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","BK1576","BK1141","BK1583","BK1161","BK1574","03347","02359","06978"],"gpt_icon":0},{"id":"2555081024","title":"历史新高！中际旭创股价突破200元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555081024","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555081024?lang=zh_cn&edition=full","pubTime":"2025-07-29 12:40","pubTimestamp":1753764056,"startTime":"0","endTime":"0","summary":"CRO、创新药板块联手大涨，苑东生物、益方生物等个股盘中股价创历史新高。截至上午收盘，上证指数下跌0.08%，深证成指下跌0.04%，创业板指上涨0.92%。药明康德2025年中报显示，公司上半年营业收入、净利润均创下历史新高。其中，公司营业收入同比增长20.64%至207.99亿元；实现净利润85.61亿元，同比增长101.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912410897249501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912410897249501&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688513","BK1161","BK1574","603259","603200","01276","603229","01093","601138","688382","688630","688660","02359","688313","06978","600276"],"gpt_icon":1},{"id":"2555089425","title":"港股异动 | 和誉-B(02256)午前涨超7% ABSK131完成首例患者给药 ABSK011临床潜力显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089425","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089425?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:53","pubTimestamp":1753761222,"startTime":"0","endTime":"0","summary":"消息面上，和誉近日宣布，其研发的新型PRMT5*MTA抑制剂ABSK131，已在针对MTAP缺失的晚期/转移性实体瘤患者的1期临床试验中完成首例患者给药。据悉，2024年12月，ABSK131获得美国食品药品监督管理局的IND批准。2025年3月，ABSK131获中国国家药品监督管理局药品审评中心的IND批准。ABSK011在初治和经治HCC患者中均展现出较大的临床潜力，未来可期在初治人群和免疫治疗失败后人群中，该方案均展现出显著临床价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2555108945","title":"港股异动 | 康方生物(09926)午前涨近3% 依沃西联合化疗1L治疗sq-NSCLC上市申请获NMPA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2555108945","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555108945?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:47","pubTimestamp":1753760835,"startTime":"0","endTime":"0","summary":"消息面上，据康方生物官微消息，7月28日，国家药品监督管理局药品审评中心官网显示，公司独立自主研发的PD-1/VEGF双特异性抗体依达方，联合化疗一线治疗晚期鳞状非小细胞肺癌的新药上市许可申请已被受理。PD-1/L1抑制剂联合化疗是NSCLC领域当前全球最优SOC，依沃西联合方案有望成为广大sq-NSCLC患者一线治疗的全新选择。据介绍，PD-1联合化疗是免疫抑制剂疗法在全球获得巨大临床突破和商业价值的核心疗法。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0417516571.SGD","BK1161","LU1720050803.USD","BK1574","09926","LU0348783233.USD","LU0348784397.USD","IE00B543WZ88.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2555089590","title":"万邦医药：公司为创新药企业提供临床试验外包服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089590?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:33","pubTimestamp":1753759992,"startTime":"0","endTime":"0","summary":"投资者提问：从国家药监局获悉：今年上半年我国批准创新药43个、创新医疗器械45个，同比分别增长59%和87%，改革政策红利正在转化为产业发展动力。去年以来，国家药监局在11个省级局开展优化药品补充申请改革试点，需要核查检验的补充申请审评时限由200个工作日缩短为60个工作日，同时，探索在30个工作日内完成重点创新药临床试验审评审批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900016323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1576","BK0216","BK1141","159992","06978","BK1161","BK1574","301520","03347"],"gpt_icon":0},{"id":"2555308984","title":"中国抗体-B盘中异动 早盘快速上涨5.13%报3.690港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555308984?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:20","pubTimestamp":1753759238,"startTime":"0","endTime":"0","summary":"2025年07月29日早盘11时20分，中国抗体-B股票出现波动，股价大幅上涨5.13%。截至发稿，该股报3.690港元/股，成交量1424.93万股，换手率1.18%，振幅6.84%。中国抗体-B股票所在的生物技术行业中，整体涨幅为3.65%。其相关个股中，创胜集团-B、药明巨诺-B、药明康德涨幅较大，振幅较大的相关个股有创胜集团-B、药明巨诺-B、北海康成-B，振幅分别为27.09%、25.12%、18.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729112038a6c6fac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729112038a6c6fac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2555089892","title":"信达生物盘中异动 早盘股价大涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089892?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:09","pubTimestamp":1753758572,"startTime":"0","endTime":"0","summary":"2025年07月29日早盘11时09分，信达生物股票出现波动，股价急速拉升3.04%。截至发稿，该股报96.750港元/股，成交量1037.74万股，换手率0.61%，振幅3.94%。资金方面，该股资金流入5.19562亿港元，流出3.05573亿港元。信达生物股票所在的药品行业中，整体跌幅为0.40%。该信息摘要如下：格隆汇7月28日｜香港交易所信息显示，贝莱德在信达生物的持股比例于07月22日从4.63%升至5.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072911093297246f8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072911093297246f8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","BK1161","LU1969619763.USD","BK1589","LU2488822045.USD","BK1583","LU2328871848.SGD"],"gpt_icon":0},{"id":"2555089899","title":"和誉-B盘中异动 快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089899?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:07","pubTimestamp":1753758464,"startTime":"0","endTime":"0","summary":"2025年07月29日早盘11时07分，和誉-B股票出现波动，股价大幅上涨5.15%。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。和誉-B股票所在的生物技术行业中，整体涨幅为3.38%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729110744a6c6f4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729110744a6c6f4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2555089805","title":"港股异动 | 三生制药(01530.HK)涨超4%再创新高 与辉瑞授权协议正式生效 1.5亿美元再售707中国内地权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089805?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:02","pubTimestamp":1753758160,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4452.SGD","LU0122379950.USD","LU1023059063.AUD","BK4581","LU0321505439.SGD","BK4550","LU1894683348.USD","LU0289739699.SGD","01530","PFE","LU0306806265.USD","IE0002270589.USD","LU1057294990.SGD","LU0170899867.USD","IE00BLSP4239.USD","LU1066053197.SGD","BK4533","LU0868494617.USD","BK4007","LU0225284248.USD","BK4585","BK1583","BK4534","BK4592","BK4599","LU1883839398.USD","LU0456855351.SGD","BK4568","SG9999002224.SGD","LU0225771236.USD","SG9999001176.USD","SG9999002232.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0321505868.SGD","SG9999001176.SGD","LU0058720904.USD","LU0985481810.HKD","SG9999013999.USD","BK1593","SGXZ57979304.SGD","BK1161","LU0306807586.USD","SG9999003800.SGD","LU1894683264.USD","SG9999011175.SGD","LU1066051498.USD","IE00BBT3K403.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2555008989","title":"和铂医药盈喜后股价涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555008989","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555008989?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:58","pubTimestamp":1753757883,"startTime":"0","endTime":"0","summary":"2025年7月28日，和铂医药-B（02142）发布公告，预期截至2025年6月30日止6个月的溢利约6800万美元至7400万美元。股价当日上涨8.33%，报10.40港元。预期溢利增长主要得益于与阿斯利康等全球制药公司的战略合作，以及新取得的创新产品许可和合作带来的收入增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072911023094c08d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072911023094c08d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2555866160","title":"百济神州：百泽安获欧洲药品管理局人用药品委员会积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2555866160","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555866160?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:45","pubTimestamp":1753757135,"startTime":"0","endTime":"0","summary":"7月29日，据$百济神州$官微消息，7月28日，公司宣布欧洲药品管理局人用药品委员会发布积极意见，推荐批准百泽安联合含铂化疗用于存在高复发风险的可切除非小细胞肺癌成人患者的术前新辅助治疗，并在术后继续使用替雷利珠单抗单药进行辅助治疗。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322972.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州：百泽安获欧洲药品管理局人用药品委员会积极意见","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","688235","BK4526","BK4087","06160","LU0588546209.SGD","BK0239","BK1500","LU2328871848.SGD","ONC","BK4139","BK1583","BK1588","LU1969619763.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2555086517","title":"全市场涨幅第一！场内唯一港股通创新药ETF（520880）飙涨3.65%！标的年内涨逾98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555086517","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555086517?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:43","pubTimestamp":1753757014,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["YANG","HSTECH","BK4614","159858","BK1574","MHImain","515120","06978","HSImain","BK1161","FDN","HHImain","BK4585","159992","07226","513600","HSI","HSCEI","BK4588","MCHmain","BK4550","02833"],"gpt_icon":0},{"id":"1196056179","title":"港股生物医药B类股盘中集体上扬，药明巨诺-B涨近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196056179","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196056179?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:42","pubTimestamp":1753756966,"startTime":"0","endTime":"0","summary":"7月29日，港股生物医药B类股盘中集体上扬，$药明巨诺-B(02126)$涨近20%，$和铂医药-B(02142)$涨近8%，$开拓药业-B(09939)$、$加科思-B(01167)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02126","BK1574","HSCEI","02142","YANG","01167","BK1583","BK1515","09939","07226","HSTECH","BK4614"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0526},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.2639},{"period":"1year","weight":0.5018},{"period":"ytd","weight":0.2743}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1161","nameEN":"BK1161"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK1161,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}